EyePoint Pharmaceuticals Inc. buy JPMorgan Chase & Co.
Start price
22.01.24
/
50%
€21.60
Target price
22.01.25
€32.12
Performance (%)
-64.19%
Price
01.07.24
€7.73
Summary
This prediction is currently active. Massive losses of -64.19% have been the result for the BUY prediction by JPMorgan_Chase___Co_. This prediction currently runs until 22.01.25. The prediction end date can be changed by JPMorgan_Chase___Co_ at any time. JPMorgan_Chase___Co_ has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
EyePoint Pharmaceuticals Inc. | -4.566% | -4.566% |
iShares Core DAX® | 1.133% | -0.156% |
iShares Nasdaq 100 | 0.815% | 8.801% |
iShares Nikkei 225® | 1.990% | 3.286% |
iShares S&P 500 | -0.014% | 5.438% |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread EyePoint Pharmaceuticals Inc. diskutieren
EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT) is now covered by analysts at JPMorgan Chase & Co.. They set an "overweight" rating and a $35.00 price target on the stock.
Ratings data for EYPT provided by MarketBeat
Stopped prediction by JPMorgan_Chase___Co_ for EyePoint Pharmaceuticals Inc.
EyePoint Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€8.46
04.06.24
04.06.24
€29.43
04.06.25
04.06.25
-8.54%
01.07.24
01.07.24